Vigilin: Could this drug target prevent a heart attack?
27 September 2016 | By ETH Zürich
Scientists identified a protein in liver cells, known as vigilin, which regulates the release of fats from the liver into the bloodstream. Find out more...
List view / Grid view
27 September 2016 | By ETH Zürich
Scientists identified a protein in liver cells, known as vigilin, which regulates the release of fats from the liver into the bloodstream. Find out more...
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
11 February 2016 | By Victoria White
The European Society of Cardiology awarded the grants to research projects that will address areas of unmet medical need in thromboembolic disease...
23 June 2014 | By Novo Nordisk
New data from the phase 3a SCALE™ Diabetes trial were presented at the International Congress of Endocrinology and the Endocrine Society’s meeting, investigating the effect of liraglutide 3 mg in adults...
22 May 2014 | By Daiichi Sankyo
Sanford-Burnham Medical Research Institute and Daiichi Sankyo Co., Ltd. announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases...